314 filings
Page 11 of 16
8-K
otbz10olrmd79w
7 Mar 18
Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
12:00am
8-K
5rtrykh2s9p9y2z84d
5 Feb 18
Departure of Directors or Certain Officers
12:00am
EFFECT
81mr2p2crp2l
9 Nov 17
Notice of effectiveness
12:00am
CORRESP
17vlb
8 Nov 17
Correspondence with SEC
12:00am
8-K
3mui0zah25u
1 Nov 17
Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates
12:00am
8-K
6uy40dhi78rj6pk
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
UPLOAD
5mvl ow1texa
25 Aug 17
Letter from SEC
12:00am
8-K
c666pkf4c zkw6r
2 Aug 17
Conatus Pharmaceuticals Reports Second Quarter 2017 Financial Results and Program Updates
12:00am
8-K
etmr2pcdiuadbyjkxkum
6 Jul 17
Other Events
12:00am
8-K
mygusuor htwjg
26 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
424B5
z1e 5nc60g
11 May 17
Prospectus supplement for primary offering
12:00am
8-K
mq6mpt
11 May 17
Conatus Announces Proposed Public Offering of Common Stock
12:00am
424B5
evx wo9ze
10 May 17
Prospectus supplement for primary offering
12:00am
8-K
0p80abtf
4 May 17
Other Events
12:00am
8-K
pm06h2ur3ulat9 kluhb
4 May 17
Conatus Pharmaceuticals Reports First Quarter 2017 Financial Results and Program Updates
12:00am